Designed for Purchasing Managers, Technical Directors & Operations Leaders who demand consistent quality, fast‑track delivery, and transparent pricing for Acipimox.
Get Free Quote in 24 hIn 2025‑2026, the global market for Acipimox API grew by 12 %, yet many corporate buyers still grapple with three persistent issues:
These pain points translate into delayed clinical trials, missed market windows, and up to 25 % lower ROI for your R&D budget.
| Parameter | Specification |
|---|---|
| Chemical Name | Acipimox (4‑(4‑Fluorophenyl)-3‑hydroxy‑5‑methyl‑2‑pyridinecarboxylic acid) |
| Purity | ≥ 99.9 % (HPLC) |
| Appearance | White to off‑white crystalline powder |
| Moisture Content | ≤ 0.1 % |
| Residual Solvents | ≤ 0.5 % (EPA‑listed) |
| Stability | Shelf life ≥ 24 months at 25 °C, 60 % RH |
| Packaging | HDPE drums (25 kg), IBC (200 kg), or sealed glass jars (≤ 5 kg) |
1. Clinical‑Stage Lipid‑Lowering Drug Development
A North‑American biotech company reduced its pre‑clinical batch failures by 22 % after switching to our GMP‑certified Acipimox, thanks to tighter impurity control.
2. Bulk Manufacturing for Generic Formulations
Our partner in Europe sourced 3 tonnes for a generic tablet line, achieving a 18 % cost saving versus legacy Chinese suppliers and met the EU’s Ph. Eur. standards without additional re‑processing.
3. Academic Research & In‑Vitro Studies
University labs in the U.S. received 250 g “research‑grade” Acipimox with a 48‑hour turnaround, enabling them to publish three high‑impact papers within the same fiscal year.
Our client portfolio includes Fortune‑500 pharma, fast‑growing biotech startups, and leading academic institutions.
Acetoacetyl-CoA-Alpha-oxoglutarate-biochemical-reagent Acetylsalicylic-acid (Tyr0)-Fibrinopeptide-A 14-3-3-protein-inhibitor-(BV02)
Our facilities hold the following internationally recognized certifications:
Standard air freight from Zhengzhou to Los Angeles takes **7 business days** after production release. Sea freight averages **21 days**. Express customs clearance is included in our service.
Yes. We offer sealed HDPE drums, IBCs, or individually labeled glass jars with batch‑specific COA. Custom labeling complies with FDA 21 CFR 210.3 and EU GMP Annex 15.
Absolutely. Our R&D team can develop tablet, capsule, or injectable formulations, providing full analytical validation, stability data, and regulatory filing support.

We accept T/T, L/C at sight, and major credit cards for smaller orders. For contracts exceeding 500 kg, Net 30 days after receipt of COA is negotiable.
Yes. Our API is manufactured under FDA‑registered GMP processes, and we provide a full IND‑ready dossier (COA, batch record, impurity profile, stability data).
Each batch undergoes HPLC, GC‑MS, and Karl Fischer moisture analysis. Results are logged in a cloud‑based LIMS system accessible to customers on demand.
Act now – the sample stock is limited to the first 50 qualified purchasers. No hidden fees, no obligation.
Request Sample & QuoteOr contact us directly: Tel: +86 199 4383 0844 | Email: service@huanqiukeji9.com
James L., Procurement Lead, MedCo (USA) – “The price transparency and on‑time delivery helped us stay under budget for Q3‑2026. Highly recommended!”
Dr. Anita Patel, Head of Chemistry, BioHealth Labs (UK) – “The purity data matched our internal standards perfectly. We saved 3 weeks on analytical validation.”
Michael S., Operations Manager, PharmaPlus (Germany) – “Fast customs clearance and full documentation meant no delays in our GMP audit. 5‑star service!”
Dr. Li Wei – Senior Pharmaceutical Engineer with 15 years of experience in API development, GMP compliance, and global supply‑chain optimization. Former Lead Scientist at a top‑10 Chinese API manufacturer and current Technical Director at Global Technology Co., Ltd.
Published author of “Modern API Manufacturing for International Markets” (2024) and regular contributor to Pharma Manufacturing Journal.
Contact Dr. Li directly: service@huanqiukeji9.com | Contact Page